2019
DOI: 10.4103/ijpm.ijpm_380_18
|View full text |Cite
|
Sign up to set email alerts
|

Effectuation to Cognize malignancy risk and accuracy of fine needle aspiration cytology in salivary gland using “Milan System for Reporting Salivary Gland Cytopathology”: A 2 years retrospective study in academic institution

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

24
24
0
1

Year Published

2019
2019
2022
2022

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 34 publications
(49 citation statements)
references
References 3 publications
24
24
0
1
Order By: Relevance
“…This was in accordance with the <5% ROM as quoted by the Milan group Karuna et al—2.44% and Rohilla et al—2.4% …”
Section: Discussionsupporting
confidence: 92%
“…This was in accordance with the <5% ROM as quoted by the Milan group Karuna et al—2.44% and Rohilla et al—2.4% …”
Section: Discussionsupporting
confidence: 92%
“…The highly cellular aspirate and presence of fibroblasts has led to misdiagnosis of benign salivary gland tumor on FNAC. Our present study more or less correlated with the studies of Kala et al, Katta et al and Karuna et al [5][6][7] There were no cases reported in Category 4b and 5. Category 6 is for the smears that are diagnostic for malignant lesion, and histological follow up of 46 cases was available.…”
Section: Discussionsupporting
confidence: 93%
“…Other 36 cases in histopathology showed concordance with cytology. Our present study more or less correlated with the studies of Kala et al, Katta et al and Karuna et al [5][6][7] FNAC is an effective tool to distinguish benign and malignant neoplasm with high specificity 98%. 8 However, sometimes it is very difficult to differentiate between a benign neoplasm and low grade malignant neoplasm.…”
Section: Discussionsupporting
confidence: 91%
See 1 more Smart Citation
“…Among all FNAs with histological follow-up, 22 out of 90 cases (24.4%) were non-neoplastic lesions, whereas 68 lesions (75.6%) were neoplastic and 16 lesions (17.8%) were malignant. The risk of neoplasm, the risk of malignancy, and the overall risk of malignancy were calculated for each MSRSGC category (Table 3) and compared with other MSRSGC studies [8,9,10,11,12,13,14,15,16,17,18,19,20,21,22,23,24,25,26] and MSRSGC estimated ROMs (Table 4).…”
Section: Resultsmentioning
confidence: 99%